People news: Astellas' Agensys and Bausch & Lomb

Share this article:
Astellas Pharma's Agensys subsidiary named Allergan's Sef Kurstjens CEO and president, replacing founder Donald Rice, who is retiring. Kurstjens, MD, PhD, was SVP, chief medical officer and head of global drug development at Allergan. Agensys is developing a pipeline of fully human monoclonal antibodies to treat solid tumor cancers.

Bausch & Lomb named Mariano Garcia-Valiño president, Latin America. Valiño was most recently an operating partner at global private equity firm Advent International, focusing on investment opportunities in Latin American pharma, and worked at Pfizer from 2001 to 2009, having headed the company's largest operating group in Brazil and led integration of Latin American operations during the Pfizer-Pharmacia merger.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters